🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to research fellow Ciputra Hartana for receiving funding from the MGH ECOR Fund for Medical Discovery (FMD) to study trained NK cells in HIV elite controllers! #ragoninstitute #elitecontrollers #HIV

So proud of Xu Yu, Assoc Prof Ragon Institute Matt Harvard University who was just awarded an NIH R37 Merit Award!! Her research on elite controllers and #hiv is super exciting- see this about her recent paper: HIV cure is possible? youtu.be/RezNiiDIzhs

A woman in Argentina has become only the second documented person whose own immune system may have cured her of HIV. nbcnews.to/3kC07Sw

A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation | Annals of Internal Medicine acpjournals.org/doi/10.7326/L2…

Great recognition for Xu Yu Ragon Institute, and her international team, from Annals of Internal Medicine-- their report characterizing an HIV cure was named one of the most influential papers of 2021! t acpjournals.org/journal/aim/be…

Congrats to Xu Yu, Mathias Lictherfeld and the rest of the Ragon Institute and broader team on their Cell publication on a roadmap for potential HIV cure! science.org/content/articl…

The Evavold lab is hiring a #postdoc. Come join us Ragon Institute and Harvard Medical School to add your diverse experiences to our goals of discovering new regulation in #metabolism, innate #immunity, and cell #death through #synbio and unbiased screens. partners.taleo.net/careersection/…

Congrats to Kyra Seiger for her presentation at #CROI2022! For a unique cohort of people living with #HIV who have been on #antiretroviraltherapy since its advent, intact HIV-1 proviruses accumulate in more transcriptionally silent regions.

See our new review on barriers to an HIV-1 cure! authors.elsevier.com/a/1fUa35Eb0Rq9…

Researchers analyzed HIV reservoirs and found that long-term antiretroviral therapy causes the immune system to select for latent reservoirs that cannot be easily reactivated. Press release: ragoninstitute.org/latest-news/lo… Cell Host & Microbe Yu & Lichterfeld Labs @ Ragon

Researchers used a new single-cell profiling technique, PheP-Seq, to study HIV reservoir cells. Results suggest that only small subsets of infected cells survive long-term ART. ragoninstitute.org/latest-news/hi… Yu & Lichterfeld Labs @ Ragon nature

In this new study, our team reports the longitudinal selection for intact proviruses integrated into heterochromatin regions after two decades of ART. cell.com/cell-host-micr…